QF
SIOX

QVT Financial’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

QVT Financial’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,375,000
Closed -$395M – 65
2017
Q4 		$395M Hold
9,375,000
– – 24.06% 2
2017
Q3 		$516M Hold
9,375,000
– – 22.07% 2
2017
Q2 		$1.74B Hold
9,375,000
– – 50.76% 1
2017
Q1 		$1.12B Hold
9,375,000
– – 39.89% 1
2016
Q4 		$932M Hold
9,375,000
– – 34.55% 1
2016
Q3 		$1.05B Buy
+9,375,000
New +$1.13B 45.7% 1
2015
Q4 		– Sell
-9,375,000
Closed -$969M – 92
2015
Q3 		$969M Hold
9,375,000
– – 40% 1
2015
Q2 		$1.53B Buy
+9,375,000
New +$1.59B 48.91% 2

Other funds holding SIOX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return